Status:
COMPLETED
Clinical Validation of Continuous and Non-invasive Monitoring of Effective Pulmonary Volume.
Lead Sponsor:
Fernando Suarez Sipmann
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate/validate a new non-invasive method to continuously monitor effective lung volume in critically ill patients.
Detailed Description
The capnodinamyc method is a new monitoring method that provides continuous (breath by breath) measurements of effective pulmonary blood flow (EPBF) and effective end-expiratory l lung volume (EELVCO2...
Eligibility Criteria
Inclusion
- All patients on mechanical ventilation in passive breathing conditions in which a thoracic CTscan has been indicated for medical reasons and those with an EIT and a continuous cardiac monitoring
- Informed consent
Exclusion
- Hemodynamic instability
- Presence of barotrauma/ pneumothorax
- Presence of bronchopleural fistulas
- Thorax alterations that preclude the positioning of the EIT electrode belt (usually at the IV intercostal space).
Key Trial Info
Start Date :
June 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2022
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04045262
Start Date
June 4 2019
End Date
March 30 2022
Last Update
October 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de la Princesa
Madrid, Spain, 28006